Perfil dos pacientes randomizados no estudo FIBRONEER-IPF, estudo de fase 3 de nerandomilast, inibidor específico de PDE 2025-02-03 13:28:01 UTC New comment Name Comment Name or nickname Your name or nickname, will be shown publicly Message At least 10 characters long By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional. Create comment
New comment